ACHV Names Erik Atkisson Chief Legal Officer Amid Critical FDA Review for Cytisinicline
Market Chameleon (Tue, 21-Oct 10:31 AM)
FDA Grants National Priority Voucher to Achieve Life Sciences: Cytisinicline Could Revolutionize Vaping Cessation
Market Chameleon (Mon, 20-Oct 10:34 AM)
ACHV Gains FDA National Priority Voucher—Expedited Pathway for First-in-Class Vaping Cessation Therapy
Market Chameleon (Fri, 17-Oct 10:31 AM)
FDA National Priority Voucher Fast-Tracks Cytisinicline: What Achieve Life Sciences' Breakthrough Means for Vaping Cessation
Market Chameleon (Fri, 17-Oct 9:41 AM)
